“One clear benefit the program brings is to widen the knowledge base and understanding of the participants of the different aspects of the Medicines Development process, resulting in a much more efficient interaction between the different departments. Medical Affairs professionals e.g. have a better understanding of where their Regulatory colleagues are coming from, and Clinical Development colleagues now have insight into how the clinical data they generate is applicable in different healthcare systems.”
“The certification programme has become very popular among our employees at all levels of seniority because the topics discussed are relevant to their work. The programme resulted not only in significant improvements in the level of knowledge about medicines development and medical affairs but also in a change in mind-set and behaviours with a favourable impact on the business and the culture.“
“I can say that Pfizer has found working with IFAPP/Kings to be a productive collaboration, offering a valuable additional element to us as we develop customized development schemes for our colleagues. It provides a comprehensive exposure to the basics of working as a pharmaceutical physician based upon an internationally-agreed curriculum and set of skills, with the added assurance of using best current educational practice. Pfizer is very happy to have been founder partners in the establishment of the program, and looks forward to a continuing fruitful engagement.”
“IFAPP-Kings College Certification Program of Medical Affairs in Medicines Development is a unique opportunity to all healthcare professionals looking for improvement of knowledge and expertise in their careers through an international experience in Medical Affairs engaged by a world-class Faculty.”
“This is a unique collaboration involving experts from academia, professional associations, regulatory agencies and biopharmaceutical companies to bring the state of the art in Medicines Development and the growing role the Medical Affairs related functions in the therapeutics life cycle through competency-based education and interactive training. The Program will produce certified competent professionals ready to serve patients, other stakeholders and the society at large”.